Valuation: IDEXX Laboratories, Inc.

Capitalization 4.21TCr 3.59TCr 3.29TCr 3.12TCr 5.78TCr 4,03100Cr 5.83TCr 39TCr 15TCr 1,91200Cr 16TCr 15TCr 6,64400Cr P/E ratio 2026 *
36.4x
P/E ratio 2027 * 32.3x
Enterprise value 4.23TCr 3.61TCr 3.31TCr 3.13TCr 5.81TCr 4,05200Cr 5.86TCr 39TCr 15TCr 1,92200Cr 16TCr 16TCr 6,67800Cr EV / Sales 2026 *
9x
EV / Sales 2027 * 8.2x
Free-Float
72.42%
Yield 2026 *
-
Yield 2027 * -
1 day+0.36%
1 week-5.16%
Current month-4.79%
1 month-5.17%
3 months-13.49%
6 months-25.18%
Current year-21.08%
1 week 524.62
Extreme 524.62
585.12
1 month 524.62
Extreme 524.62
594.52
Current year 524.62
Extreme 524.62
726.41
1 year 496.61
Extreme 496.61
769.98
3 years 356.14
Extreme 356.14
769.98
5 years 317.06
Extreme 317.06
769.98
10 years 85.98
Extreme 85.98
769.98
Manager TitleAgeSince
Chief Executive Officer 52 12/05/2026
Director of Finance/CFO 43 01/03/2025
Chief Operating Officer 58 01/01/2025
Director TitleAgeSince
Chairman 65 12/05/2026
Director/Board Member 64 15/07/2013
Director/Board Member 73 11/03/2014
Change 5d. change 1-year change 3-years change Capi.($)
+0.36%-5.16%+4.79%+9.53% 4.21TCr
Average +0.36%-5.16%+4.79%+9.53% 4.21TCr
Weighted average by Cap. +0.36%-5.16%+4.79%+9.53%

Financials

2026 *2027 *
Net sales 470.24Cr 401.07Cr 367.83Cr 348.18Cr 645.26Cr 45TCr 651.42Cr 4.38TCr 1.71TCr 21TCr 1.76TCr 1.73TCr 74TCr 511Cr 435.84Cr 399.72Cr 378.36Cr 701.2Cr 49TCr 707.89Cr 4.76TCr 1.85TCr 23TCr 1.92TCr 1.88TCr 81TCr
Net income 116.89Cr 100Cr 91Cr 87Cr 160.4Cr 11TCr 161.93Cr 1.09TCr 424.09Cr 5.31TCr 438.63Cr 429.38Cr 18TCr 130.38Cr 111.2Cr 101.98Cr 97Cr 178.9Cr 12TCr 180.61Cr 1.21TCr 473Cr 5.92TCr 489.22Cr 478.91Cr 21TCr
Net Debt 21Cr 18Cr 17Cr 16Cr 29Cr 2.05TCr 30Cr 199.21Cr 78Cr 970.76Cr 80Cr 79Cr 3.37TCr -23Cr -20Cr -18Cr -17Cr -32Cr -2.23TCr -32Cr -216.93Cr -84Cr -1.06TCr -87Cr -86Cr -3.67TCr
Logo IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc. is a world leader in the design, development and marketing of diagnostic test instruments for animal health monitoring and analysis of dairy products and water. Net sales break down by area of application as follows: - veterinary diagnoses for pets (91.8%); - water quality analysis (4.7%); - veterinary diagnoses for livestock and poultry (3.1%): solutions that help detect infectious diseases in ruminants, pigs, poultry and horses. The group also offers test solutions for dairy products; - other (0.4%). Net sales by source of income break down between product sales (57.7%) and services (42.3%). Net sales are distributed geographically as follows: the United States (65%), Canada (3.9%), Americas (2.1%), Germany (4.5%), the United Kingdom (3.5%), France (2.9%), Spain (1.6%), Italy (1.5%), Switzerland (0.9%), Netherlands (0.9%), Europe/Middle East/Africa (5.1%), Australia (2.5%), Japan (1.9%), China (0.9%) and Asia/Pacific (2.8%).
Employees
11,000
Date Price Change Volume
12/26/12 533.92 $ +0.36% 6,74,172
11/26/11 532.00 $ -5.02% 7,61,446
08/26/08 560.11 $ -2.11% 4,76,636
07/26/07 572.20 $ -1.21% 7,58,922
06/26/06 579.23 $ +2.89% 6,65,236
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
533.92USD
Average target price
709.14USD
Spread / Average Target
+32.82%

Quarterly revenue - Rate of surprise